drugset / Trial / NCT02837770

Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections

NCT02837770

Completed 76 enrolled University Hospital of Patras
RandomizedParallel-groupTriple-blindSupportive care

Summary

The analgestic efffect of Diclofenac Sodium 0.1% Eye Drops and a combination of Diclofenac Sodium 0.1% Eye Drops and oral Diclofenac Sodium sustained-release 75mg tablets on pain related to intravitreal injections will be evalutated. Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.

Timeline

Start
2016-07
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 0.1 % Topical
Comparator Diclofenac Other / unclassified 75 mg Topical

Indications

No indication recorded.